 Stroke Volume
"Stroke Volume" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.
| Descriptor ID |
D013318
|
| MeSH Number(s) |
E01.370.370.380.150.700 G09.330.380.124.882
|
| Concept/Terms |
Stroke Volume- Stroke Volume
- Stroke Volumes
- Volume, Stroke
- Volumes, Stroke
Ventricular End-Systolic Volume- Ventricular End-Systolic Volume
- End-Systolic Volume, Ventricular
- End-Systolic Volumes, Ventricular
- Ventricular End Systolic Volume
- Ventricular End-Systolic Volumes
- Volume, Ventricular End-Systolic
- Volumes, Ventricular End-Systolic
Ventricular Ejection Fraction- Ventricular Ejection Fraction
- Ejection Fraction, Ventricular
- Ejection Fractions, Ventricular
- Fraction, Ventricular Ejection
- Fractions, Ventricular Ejection
- Ventricular Ejection Fractions
Ventricular End-Diastolic Volume- Ventricular End-Diastolic Volume
- End-Diastolic Volume, Ventricular
- End-Diastolic Volumes, Ventricular
- Ventricular End Diastolic Volume
- Ventricular End-Diastolic Volumes
- Volume, Ventricular End-Diastolic
- Volumes, Ventricular End-Diastolic
|
Below are MeSH descriptors whose meaning is more general than "Stroke Volume".
Below are MeSH descriptors whose meaning is more specific than "Stroke Volume".
This graph shows the total number of publications written about "Stroke Volume" by people in this website by year, and whether "Stroke Volume" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 | | 1997 | 3 | 4 | 7 | | 1998 | 0 | 2 | 2 | | 2000 | 0 | 1 | 1 | | 2001 | 0 | 3 | 3 | | 2002 | 0 | 4 | 4 | | 2003 | 1 | 5 | 6 | | 2004 | 0 | 5 | 5 | | 2005 | 0 | 4 | 4 | | 2006 | 0 | 2 | 2 | | 2007 | 0 | 7 | 7 | | 2008 | 0 | 5 | 5 | | 2009 | 1 | 4 | 5 | | 2010 | 2 | 4 | 6 | | 2011 | 3 | 5 | 8 | | 2012 | 4 | 6 | 10 | | 2013 | 7 | 6 | 13 | | 2014 | 2 | 8 | 10 | | 2015 | 5 | 11 | 16 | | 2016 | 3 | 13 | 16 | | 2017 | 6 | 17 | 23 | | 2018 | 6 | 12 | 18 | | 2019 | 9 | 15 | 24 | | 2020 | 6 | 16 | 22 | | 2021 | 7 | 21 | 28 | | 2022 | 0 | 27 | 27 | | 2023 | 0 | 36 | 36 | | 2024 | 14 | 10 | 24 | | 2025 | 5 | 14 | 19 |
To return to the timeline, click here.
Below are the most recent publications written about "Stroke Volume" by people in Profiles.
-
Miles KG, Ta HT, Bjorkman KR, Gao Z, Ollberding NJ, Hirsch R, Ivy DD, Lang SM, Cash M, Magness M, O'Neil M, Luebbe K, Frank BS, Critser PJ. Right Atrial Function is Impaired in Pediatric Pulmonary Arterial Hypertension: A Multi-center Cardiovascular Magnetic Resonance Study. J Cardiovasc Magn Reson. 2025 Winter; 27(2):101962.
-
Harrington JL, Canonico ME, El Rafei A, Solomon SD, Teerlink JR, Vaduganathan M, Zieroth SR, Bonaca MP, Sauer AJ. Nonsteroidal and Steroidal Mineralocorticoid Antagonists: Rationale, Evidence, and Unanswered Questions. JACC Heart Fail. 2025 Oct; 13(10):102637.
-
Zannad F, O'Connor CM, Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Gates D, Ezekowitz JA, Hernandez AF, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Armstrong PW. Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials. Lancet. 2025 Sep 27; 406(10510):1351-1362.
-
Butler J, McMullan CJ, Anstrom KJ, Barash I, Bonaca MP, Borentain M, Corda S, Ezekowitz JA, Felker GM, Gates D, Lam CSP, Lewis EF, Lindenfeld J, Mentz RJ, O'Connor CM, Ponikowski P, Reddy YNV, Rosano GMC, Saldarriaga C, Senni M, She L, Teixeira PP, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Zannad F. Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet. 2025 Sep 27; 406(10510):1341-1350.
-
Zannad F, Reddy YNV, Barash I, Anstrom KJ, Bonaca MP, Borentain M, Corda S, Teixeira PP, Ezekowitz JA, Gates D, Lam CSP, Lewis EF, Lindenfeld J, McMullan CJ, Mentz RJ, O'Connor CM, Ponikowski P, Rosano GMC, Saldarriaga C, Senni M, Udelson J, Urbinati A, Vlajnic V, Voors AA, Xing A, Patel MJ, Butler J. Effect of Vericiguat on Total Heart Failure Events in Compensated Outpatients With HFrEF: Insights From VICTOR. J Am Coll Cardiol. 2025 Dec 16; 86(24):2471-2491.
-
Maw AM, Wright GC, Bean MR, Allen LA, Matlock DD, Cervantes L, Glasgow RE, Huebschmann AG, Colborn KL, Houston TK, Trinkley KE. Frequency and Predictors of Virtual Visits in Patients With Heart Failure Within a Large Health System: Retrospective Cohort Study. J Med Internet Res. 2025 Aug 12; 27:e70414.
-
Trongtorsak A, De La Rosa Martinez J, Crawford TC, Bogun FM, Gu X, Puroll E, Ellenbogen KA, Chicos AB, Roukoz H, Zimetbaum PJ, Kalbfleisch SJ, Murgatroyd FD, Steckman DA, Rosenfeld LE, Soejima K, Bhan AK, Vedantham V, Dickfeld TL, DeLurgio DB, Platonov PG, Zipse MM, Nishiuchi S, Ortman ML, Narasimhan C, Patton KK, Rosenthal DG, Mukerji SS, Hoogendoorn JC, Zeppenfeld K, Torosoff M, Judson MA, Martin K, Madias C, Hermel M, Nour K, Torbey E, Sauer WH, Kron J. Race Comparisons in Patients With Cardiac Sarcoidosis: Insights From the Cardiac Sarcoidosis Consortium. Circ Arrhythm Electrophysiol. 2025 Jul; 18(7):e013670.
-
Martinez-Morata I, Domingo-Relloso A, Mayer M, Schilling K, Glabonjat RA, McGraw K, Sanchez TR, Kaufman JD, Vaidya D, Post W, Jones M, Shimbo D, Zhang Y, Fretts AM, Pichler G, Umans JG, Garcia Pinilla JM, Cole SA, Martin-Escudero JC, Redon J, Grau-Perez M, Barr RG, Valeri L, Shea S, Tellez-Plaza M, Devereux RB, Navas-Acien A. Associations Between Urinary Metal Levels and Incident Heart Failure: A Multi-Cohort Analysis. JACC Heart Fail. 2025 Aug; 13(8):102510.
-
Rafei AE, Harrington JA, Tavares CAM, Guimarães PO, Ambrosy AP, Bonaca MP, Sauer AJ, Vardeny O, Canonico ME. Heart failure with preserved ejection fraction therapeutics: in search of the pillars. Heart Fail Rev. 2025 Sep; 30(5):1005-1014.
-
Setti M, Iseppi M, Verdonschot JAJ, Rizzi JG, Paldino A, Pio Loco Detto Gava C, Barbati G, Dal Ferro M, Venner MFGHM, Raafs AG, Gigli M, Stolfo D, De Luca A, De Angelis G, Capovilla TM, Graw S, Ribichini FL, Taylor M, Mestroni L, Heymans SRB, Sinagra G, Merlo M. Integrated role of cardiac magnetic resonance and genetics in predicting left ventricular reverse remodelling in dilated and non-dilated cardiomyopathy. Eur J Heart Fail. 2025 Nov; 27(11):2571-2581.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|